Modulation of hematopoietic stem cell homing and engraftment by CD26

Science

Volumn 305, Issue 5686, 2004, Pages 1000-1003

  Christopherson II, Kent W ^a,b,c   Hangoc, Giao ^a,b   Mantel, Charlie R ^a,b   Broxmeyer, Hal E ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTHER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; ENZYME INHIBITION; PROTEINS; TRANSPLANTATION (SURGICAL);

BONE MARROW; STEM CELLS;

CELL CULTURE;

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); CHEMOKINE RECEPTOR CXCR4; DIPEPTIDE; DIPEPTIDYL PEPTIDASE IV; DIPROTIN A;

MEDICINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD26; CELL CYCLE; CELL MOVEMENT; CELL SURVIVAL; CHEMOKINES, CXC; CHEMOTAXIS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HETEROCYCLIC COMPOUNDS; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES; RECEPTORS, CXCR4;

ANIMALIA;

EID: 4043117769     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1097071     Document Type: Article

References (32)

1. H. E. Broxmeyer et al., Proc. Natl. Acad. Sci. U.S.A. 86, 3828 (1989).
2. E. Gluckman et al., N. Engl. J. Med. 321, 1174 (1989).
3. H. E. Broxmeyer, F. Smith, in Thomas' Hematopoietic Cell Transplantation, K. G. Blume, S. J. Forman, F. R. Appelbaum, Eds. (Blackwell Science, Oxford; Malden, MA, 2004), chap. 43, pp. 550-564.
4. E. J. Shpall et al., Biol. Blood Marrow Transplant. 8, 368 (2002).
5. J. Jaroscak et al., Blood 101, 5061 (2003).
6. H. Ema, H. Nakauchi, Immunity 20, 1 (2004).
7. P. Benveniste, C. Cantin, D. Hyam, N. N. Iscove, Nature Immunol. 4, 708 (2003).
8. Y. Matsuzaki, K. Kinjo, R. C. Mulligan, H. Okano, Immunity 20, 87 (2004).
9. K. W. Christopherson 2nd, G. Hangoc, H. E. Broxmeyer, J. Immunol. 169, 7000 (2002).
10. K.W. Christopherson 2nd, S. Cooper, H. E. Broxmeyer, Blood 101, 4680 (2003).
11. K. W. Christopherson 2nd, S. Cooper, G. Hangoc, H. E. Broxmeyer, Exp. Hematol. 31, 1126 (2003).
12. G. J. Spangrude, S. Heimfeld, I. L. Weissman, Science 241, 58 (1988).
13. D. E. Harrison, Blood 55, 77 (1980).
14. Materials and methods are available as supporting material on Science Online.
15. M. M. Rosenkilde et al., J. Biol. Chem. 279, 3033 (2004).
16. D. E. Wright, E. P. Bowman, A. J. Wagers, E. C. Butcher, I. L. Weissman, J. Exp. Med. 195, 1145 (2002).
17. K. Hattori et al., Blood 97, 3354 (2001).
18. H. E. Broxmeyer et al., Blood 100, 609a (abstr. no. 2397) (2002).
19. C. W. Liles et al., Blood 102, 2728 (2003).
20. A. Peled et al., Science 283, 845 (1999).
21. H. E. Broxmeyer, Int. J. Hematol. 74, 9 (2001).
22. T. Ara et al., Immunity 19, 257 (2003).
23. C. H. Kim, H. E. Broxmeyer, Blood 91, 100 (1998).
24. H. E. Broxmeyer et al., J. Immunol. 170, 421 (2003).
25. H. E. Broxmeyer et al., J. Leukoc. Biol. 73, 630 (2003).
26. O. Kollet et al., Stood 100, 2778 (2002).
27. D. E. Harrison, C. T. Jordan, R. K. Zhong, C. M. Astle, Exp. Hematol. 21, 206 (1993).
28. A. Gothot, J. C. van der Loo, D. W. Clapp, E. F. Srour, Blood 92, 2641 (1998).
29. T. Yahata et al., Blood 101, 2905 (2003).
30. J. Wang et al., Blood 101, 2924 (2003).
31. F. Mazurier, M. Doedens, O. I. Gan, J. E. Dick, Nature Med. 9, 959 (2003).
32. These studies were supported by U.S. Public Health Science Grants R01 DK53674, R01 HL67384, and R01 HL56416 to H.E.B. K.W.C. was supported sequentiatty during these studies by NIH training grant T32 DK07519 to H.E.B. and by a Fellow Award from the Leukemia and Lymphoma Society to K.W.C.